Google Alert - non small cell lung cancer treatment

News 1 new result for non small cell lung cancer treatment

Celgene (CELG) Updates on ABRAXANE Phase III; Plans on Submitting sNDA to FDA StreetInsider.com (subscription) Celgene International (Nasdaq: CELG) has presented final results from a phase III study of ABRAXANE (paclitaxel albumin-bound particles for injectable suspension) in combination with carboplatin in patients with advanced non-small cell lung cancer ... See all stories on this topic »

Web 1 new result for non small cell lung cancer treatment

GTx Announces Agreement with FDA on Phase III Clinical Development ... "A medical intervention which helps non-small cell lung cancer patients stay strong would be an important addition to the treatment armamentarium." ... eon.businesswire.com/news/eon/20110606005604/en/.../GTx

---

Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Remove this alert.
Create another alert.
Manage your alerts.